Pacira Pharmaceuticals reported $169.41M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.57M 0.13M
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Amerisourcebergen ABC:US $ 60064.6M 2345.16M
Astellas Pharma 4503:JP Y 381791M 77921M
Bristol Myers Squibb BMY:US $ 11887M 239M
Cara Therapeutics CARA:US $ 23M 18.21M
Coherus Biosciences CHRS:US $ 60.15M 0.04M
Depomed DEPO:US $ 35.13M 1.41M
Endo International Ordinary Shares ENDP:US $ 569.11M 83.14M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Horizon Pharma HZNP:US $ 876.41M 8.83M
Ironwood Pharmaceuticals IRWD:US $ 97.23M 0.3M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Johnson & Johnson JNJ:US $ 24020M 594M
Lannett LCI:US $ 78.36M 8.15M
Ligand Pharmaceuticals LGND:US $ 83.64M 37.95M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Perrigo Ordinary Shares PRGO:US $ 1121.7M 47.2M
Pfizer PFE:US $ 27742M 2081M
Revance Therapeutics RVNC:US $ 28.37M 3.11M
Supernus Pharmaceuticals SUPN:US $ 170.05M 17.55M
Teva Pharmaceutical TEVA:IT 3.79B 125M
Xeris Pharmaceuticals Inc XERS:US $ 25.31M 3.23M
Xoma XOMA:US $ 983K 2.12M
Zoetis ZTS:US $ 2052M 66M